RETRACTED: De Novo HER2 S310Y mutation associates with poor response to EGFR tyrosine kinase inhibitor in activating EGFR-mutant NSCLC patient: A case report
- DOI
- 10.1177/2058739219827166
- Published
- 2019-02-20
- Container
- European Journal of Inflammation
- Publisher
- SAGE Publications
- Open access
- unknown
Credibility signals
serious concern Score 29/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- serious concernRetraction Watch retraction: 1 retraction notice matched this DOI.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1177/2058739219827166,
title = {RETRACTED: De Novo HER2 S310Y mutation associates with poor response to EGFR tyrosine kinase inhibitor in activating EGFR-mutant NSCLC patient: A case report},
author = {Fei Gao and Xiuyan Wu and Jie Wu and Yanlin Li and Zhibo Miao and Lei Song},
year = {2019},
journal = {European Journal of Inflammation},
doi = {10.1177/2058739219827166},
url = {https://doi.org/10.1177/2058739219827166}
}RIS
TY - JOUR TI - RETRACTED: De Novo HER2 S310Y mutation associates with poor response to EGFR tyrosine kinase inhibitor in activating EGFR-mutant NSCLC patient: A case report AU - Fei Gao AU - Xiuyan Wu AU - Jie Wu AU - Yanlin Li AU - Zhibo Miao AU - Lei Song PY - 2019 JO - European Journal of Inflammation DO - 10.1177/2058739219827166 UR - https://doi.org/10.1177/2058739219827166 ER -
APA
Gao, F., Wu, X., Wu, J., Li, Y., Miao, Z., & Song, L. (2019). RETRACTED: De Novo HER2 S310Y mutation associates with poor response to EGFR tyrosine kinase inhibitor in activating EGFR-mutant NSCLC patient: A case report. European Journal of Inflammation. https://doi.org/10.1177/2058739219827166
Source records
- crossref · retrieved 2026-09-24T20:13:01.053Z